Science and Research

MK-7339-006

A phase III Study, Pembrolizumab in Combination with Pemetrexed/Platinum followed by Pembrolizumab and maintenance Olaparib vs. Maintenance Pemetrexed in firstline treatment of NSCLC non-squamous

Study details
Study-ID: NCT03976323, 2018-004720-11
DZL Disease Area: LC
DZL Disease Area: LC
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL recruiting center
DZL Role: DZL recruiting center
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: CPC-M
DZL Participating Sites: CPC-M
Start Date: 28.06.2019
Completion Date: 13.01.2025
Status: Closed
Status: Closed
DZL recruiting center
Link to Study


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.